Vol. 46 No. 3 (2007): Acta Oncologica

Articles

• Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer

  Efraim Idelevich, Natalie Karminsky, Michael Dinerman, Rivka L. Katsenelson, Nana Ben Zvi, Noa Ben Baruch, Haim Biran, Sofia Man , Adi Shani

  324-329

  Published: 2007-01-01

  • PDF

• CYP450 polymorphisms predict clinic outcomes to vinorelbine-based chemotherapy in patients with non-small-cell lung cancer

  Ji-Hong Pan, Jin-Xiang Han, Jian-Mei Wu, Li-Jun Sheng , Hai-Nan Huang

  361-366

  Published: 2007-01-01

  • PDF

• Fractionation sensitivity and equivalent doses. Commenting on the editorial by Glimelius

  Adel Courdi

  395-396

  Published: 2007-01-01

  • PDF

• Obesity – incidence and mortality from gastrointestinal tract cancers

  Alicja Wolk

  402-404

  Published: 2007-01-01

  • PDF

• Short and long-term survival from gastric cancer. A population-based study from a county hospital during 25 years

  Elisabeth Lello, Bjørg Furnes , Tom-H. Edna

  308-315

  Published: 2007-01-01

  • PDF

• Diet and vitamin or mineral supplementation and risk of rectal cancer in Canada

  Jinfu Hu, Les Mery, Marie Desmeules, Monica MacLeod

  342-354

  Published: 2007-01-01

  • PDF

• Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: Potential for drug targe

  Kanlayanee Sawanyawisuth, Chaisiri Wongkham, Chawalit Pairojkul, O-Tur Saeseow, Gregory J. Riggins, Norie Araki , Sopit Wongkham

  378-385

  Published: 2007-01-01

  • PDF

• Gastrointestinal tract cancers – global burden and trends

  Timo Hakulinen

  400-401

  Published: 2007-01-01

  • PDF

• Adrenaline and nicotine interaction in the pathogenesis of colon cancer

  Chi Hin Cho, Helen Pui Shan Wong

  407-408

  Published: 2007-01-01

  • PDF

• Advances in the treatment of patients with gastric adenocarcinoma

  Theodoros Foukakis, Lars Lundell, Michael Gubanski, Pehr A. Lind

  277-285

  Published: 2007-01-01

  • PDF

• Phase I study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first line therapy in patients with non-resectable gastric cancer

  Jeanette Dupont, Helle A. Jensen, Benny V. Jensen, Per Pfeiffer

  330-335

  Published: 2007-01-01

  • PDF

• Measurement and impact of co-morbidity in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. A phase II study of weekly paclitaxel

  Oscar Juan, Ana Albert, Juan M. Campos, Vicente Caranyana, José Muñoz , Vicente Alberola

  367-373

  Published: 2007-01-01

  • PDF

• In reply to Dr Courdi

  Bengt Glimelius, Ulf Isacsson

  396

  Published: 2007-01-01

  • PDF

• Dietary factors in gastrointestinal tract cancers – an Asian perspective

  Shoichiro Tsugane

  405-406

  Published: 2007-01-01

  • PDF

• Humoral immune response to MUC1 and to the Thomsen-Friedenreich (TF) glycotope in patients with gastric cancer: Relation to survival

  O. Kurtenkov, K. Klaamas, S. Mensdorff-Pouilly, L. Miljukhina, L. Shljapnikova , V. Chužmarov

  Published: 2023-11-15

  • PDF

• Influence of long-term colonoscopic surveillance on incidence of colorectal cancer and death from the disease in patients with precursors (adenomas)

  Ole Dan Jørgensen, Ole Kronborg, Claus Fenger , Morten Rasmussen

  355-360

  Published: 2007-01-01

  • PDF

• Volumetric staging (VS) is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRT

  G. Studer, U. M. Lütolf, M. El-Bassiouni, V. Rousson, C. Glanzmann

  386-394

  Published: 2007-01-01

  • PDF

• Environment and genetics in the etiology of gastrointestinal tract cancers

  Kari Hemminki

  401-402

  Published: 2007-01-01

  • PDF

• Chemoprevention of gastrointestinal cancer

  John A. Baron

  408-409

  Published: 2007-01-01

  • PDF

• Nordic biological specimen banks as basis for studies of cancer causes and control – more than 2 million sample donors, 25 million person years and 100 000 prospective cancers

  Eero Pukkala, Aage Andersen, Göran Berglund, Randi Gislefoss, Vilmundur Gudnason, Göran Hallmans, Egil Jellum, Pekka Jousilahti, Paul Knekt, Pentti Koskela, P. Pentti Kyyrönen, Per Lenner, Tapio Luostarinen, Arthur Löve, Helga Ögmundsdóttir, Pär Stattin, Leena Tenkanen, Laufey Tryggvadóttir, Jarmo Virtamo, Göran Wadell, Anders Widell, Matti Lehtinen , Joakim Dillner

  286-307

  Published: 2007-01-01

  • PDF

• A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer

  Sung Yong Oh, Hyuk-Chan Kwon, Bong-Gun Seo, Sung-Hyun Kim, Jae-Seok Kim, Hyo-Jin Kim

  Published: 2023-11-15

• A phase II study using vinorelbine and continuous 5-fluorouracil in patients with advanced head and neck cancer

  Susanne Larsen, Eva Serup-Hansen, Lisbeth J. Andersen, Birgit Lindeløv, Tine McCulloch, Parvin Adimi, Lars Bastholt

  374-377

  Published: 2023-11-16

  • PDF

• Efficacy and safety of cisplatin and capecitabine in combination as first line treatment for unselected patients with advanced gastric cancer

  Ainhoa Viteri, Alberto Muñoz, Itziar Rubio, Ramón Barceló, Alejandro Martínez-Bueno, Ricardo Fernández, Sergio Carrera, Guillermo López-Vivanco

  397-399

  Published: 2007-01-01

  • PDF

• Interaction of alcohol, colonic bacteria and genes in the pathogenesis of colorectal cancer

  Helmut K. Seitz

  406-407

  Published: 2007-01-01

  • PDF